Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents.
暂无分享,去创建一个
[1] E. Romagnoli,et al. Modified T‐stenting with intentional protrusion of the side‐branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: The T‐stenting and small protrusion technique (TAP‐stenting). Report of bench testing and first clinical Italian‐Korean two‐centre exp , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[2] M. Buchbinder,et al. Long‐term outcomes of bifurcation lesions after implantation of drug‐eluting stents with the “mini‐crush technique” , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] H. Ho,et al. Stenting of coronary bifurcation lesions by using modified crush technique with double kissing balloon inflation (sleeve technique): Immediate procedure result and short‐term clinical outcomes , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[4] Hadar Marom,et al. Bifurcation lesions in the coronary arteries: early experience with a novel 3-dimensional imaging and quantitative analysis before and after stenting. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[6] J. Suárez de Lezo,et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. , 2007, American heart journal.
[7] M. Niemelä,et al. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study , 2006, Circulation.
[8] P. Serruys,et al. Bifurcation stenting with drug eluting stents: Illustration of the crush technique , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] P. Serruys,et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. , 2006, Journal of the American College of Cardiology.
[10] Gregg W Stone,et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". , 2006, The American journal of cardiology.
[11] A. Colombo. Stenting bifurcations: The last frontier for fantasy in coronary interventions , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] Alfonso Medina,et al. Una clasificación simple de las lesiones coronarias en bifurcación , 2006 .
[13] J. Suárez de Lezo,et al. [A new classification of coronary bifurcation lesions]. , 2006, Revista espanola de cardiologia.
[14] Douglas Scott,et al. Drug‐eluting stents for coronary bifurcations: Bench testing of provisional side‐branch strategies , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] I. Iakovou,et al. Cardiac Pacemaker ( If ) Current : Physiological and Pharmacological Properties , 2006 .
[16] W. Bamlet,et al. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. , 2005, Journal of the American College of Cardiology.
[17] I. Iakovou,et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. , 2005, Journal of the American College of Cardiology.
[18] G. Stone,et al. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. , 2005, Journal of the American College of Cardiology.
[19] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[20] V. Džavík,et al. Balloon crush: Treatment of bifurcation lesions using the crush stenting technique as adapted for transradial approach of percutaneous coronary intervention , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[21] M. Pan,et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. , 2004, American heart journal.
[22] E. Currie,et al. Drug‐eluting stents for coronary bifurcations: Insights into the crush technique , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] P. Serruys,et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. , 2004, The American journal of cardiology.
[24] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.
[25] Patrick W Serruys,et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry , 2004, Circulation.
[26] K. Detre,et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.
[27] A Benslimane,et al. Stenting of bifurcation lesions: Classification, treatments, and results , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[28] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.
[29] F H Sheehan,et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.